FDA staff question peptides backed by Kennedy ahead of advisory panel review
By Sneha S KU.S. FDA staff reviewers said there is little evidence to allow compounding pharmacies to manufacture seven popular peptides, in stark contrast to Health Secretary Robert F. Kennedy Jr, who has publicly endorsed the compounds and said he is a "big fan".The remarks, outlined in documents…